Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
Clinical trial NCT00619502 · COMPLETED
Trial details
- NCT number
- NCT00619502
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.